AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

A-04 Prevention and Treatment for Liver Cancer

Technology Benefits

ΓùÅ Providing effective treatment for liver cancer or preventive medicine for liver cancerΓùÅ Available Orally

Technology Application

ΓùÅ Suitable as preventive medicine for liver cancerΓùÅ New therapeutic method for liver cancer

Detailed Technology Description

This technology provides a method to prevent and treat liver cancer. The inhibition of liver cancer development was observed in a rat model by injecting both menatetrenone (a type of vitamin K) and phospholipids (preferably egg yolk lecithin or soybean lecithin). This compound can be formulated as tablets, granules, capsule, syrup, injection, or ointment.

Supplementary Information

Inventor: NAKAO, Akimasa | SAKAKIMA, Katsutoshi
Priority Number: WO2007091557A1
IPC Current: A61K0031122 | A61K0031685 | A61P003500
Assignee Applicant: National University Corporation Nagoya University
Title: PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF LIVER CANCER | PRÉPARATION PHARMACEUTIQUE POUR LE TRAITEMENT OU LA PRÉVENTION DU CANCER DU FOIE
Usefulness: PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF LIVER CANCER | PRÉPARATION PHARMACEUTIQUE POUR LE TRAITEMENT OU LA PRÉVENTION DU CANCER DU FOIE
Summary: For treating or preventing hepatic carcinoma (claimed).
Novelty: Pharmaceutical composition useful for preventing or treating hepatic carcinoma, comprises vitamin K and phosphatide

Industry

Disease Diagnostic/Treatment

Sub Group

Cancer/Tumor

Country/Region

USA

For more information, please click Here